Literature DB >> 11095746

MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

S B Deitz1, D A Dodd, S Cooper, P Parham, K Kirkegaard.   

Abstract

The effects of poliovirus 3A protein expression and poliovirus infection on the presentation of hepatitis C virus antigens in cultured chimpanzee cells were examined. Expression of poliovirus 3A protein inhibits protein secretion when expressed in isolation and was sufficient to protect chimpanzee cells from lysis by hepatitis C virus-specific cytotoxic T cells in standard (51)Cr-release assays. Poliovirus infection also inhibited antigen presentation, as determined by decreased cytotoxic T cell activation. A mutation in 3A that abrogates the inhibition of protein secretion also abolished the effects of poliovirus on antigen presentation. These results demonstrate that the inhibition of secretion observed in poliovirus-infected cells substantially reduces the presentation of new antigens on the cell surface. These observations may reflect a general mechanism by which nonenveloped viruses such as poliovirus and other viruses that do not require a functional protein secretory apparatus can evade detection by the cellular immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095746      PMCID: PMC17654          DOI: 10.1073/pnas.250483097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS.

Authors:  S DALES; H J EGGERS; I TAMM; G E PALADE
Journal:  Virology       Date:  1965-07       Impact factor: 3.616

2.  The functional half-life of H-2Kd-restricted T cell epitopes on living cells.

Authors:  G Eberl; C Widmann; G Corradin
Journal:  Eur J Immunol       Date:  1996-09       Impact factor: 5.532

3.  Selection of recombinant vaccinia viruses on the basis of plaque formation.

Authors:  R Blasco; B Moss
Journal:  Gene       Date:  1995-06-09       Impact factor: 3.688

4.  FACS-optimized mutants of the green fluorescent protein (GFP).

Authors:  B P Cormack; R H Valdivia; S Falkow
Journal:  Gene       Date:  1996       Impact factor: 3.688

5.  Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.

Authors:  M Kutubuddin; J Simons; M Chow
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Induction of membrane proliferation by poliovirus proteins 2C and 2BC.

Authors:  R Aldabe; L Carrasco
Journal:  Biochem Biophys Res Commun       Date:  1995-01-05       Impact factor: 3.575

7.  Cellular origin and ultrastructure of membranes induced during poliovirus infection.

Authors:  A Schlegel; T H Giddings; M S Ladinsky; K Kirkegaard
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells.

Authors:  M W Cho; N Teterina; D Egger; K Bienz; E Ehrenfeld
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

9.  Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A.

Authors:  J R Doedens; K Kirkegaard
Journal:  EMBO J       Date:  1995-03-01       Impact factor: 11.598

10.  Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

Authors:  B P Mahon; K Katrak; A Nomoto; A J Macadam; P D Minor; K H Mills
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  82 in total

1.  Intracellular topology and epitope shielding of poliovirus 3A protein.

Authors:  Sunny S Choe; Karla Kirkegaard
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 3.  Expanding knowledge of P3 proteins in the poliovirus lifecycle.

Authors:  Craig E Cameron; Hyung Suk Oh; Ibrahim M Moustafa
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

4.  Dendritic cells and macrophages are productively infected by poliovirus.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Inhibition of protein trafficking by coxsackievirus b3: multiple viral proteins target a single organelle.

Authors:  Christopher T Cornell; William B Kiosses; Stephanie Harkins; J Lindsay Whitton
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.

Authors:  Armando M De Palma; Hendrik Jan Thibaut; Lonneke van der Linden; Kjerstin Lanke; Ward Heggermont; Stephen Ireland; Robert Andrews; Murty Arimilli; Taleb H Al-Tel; Erik De Clercq; Frank van Kuppeveld; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2009-02-23       Impact factor: 5.191

8.  Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis.

Authors:  Trever B Burgon; Jomaquai A Jenkins; Stephen B Deitz; Jeannie F Spagnolo; Karla Kirkegaard
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Escape from transcriptional shutoff during poliovirus infection: NF-κB-responsive genes IκBa and A20.

Authors:  Tammy Doukas; Peter Sarnow
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 10.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.